Orion traded at 80.90 this Thursday October 1st, decreasing 2.20 or 2.65 percent since the previous trading session. Looking back, over the last four weeks, Orion lost 0.56 percent. Over the last 12 months, its price rose by 23.32 percent. Looking ahead, we forecast Orion to be priced at 80.83 by the end of this quarter and at 74.78 in one year, according to Trading Economics global macro models projections and analysts expectations.
Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.